As of 2025-11-03, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 14.3x | 9.6x |
| Forward P/E multiples | 9.1x - 19.5x | 14.8x |
| Fair Price | (86.81) - (112.60) | (102.35) |
| Upside | -6530.2% - -8440.9% | -7681.7% |
| Date | EV/EBITDA |